Clene Inc.
CLNNNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for CLNN. That does not mean none is planned.
Get an email about CLNN's next catalysts
Track Clene (CLNN) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming, 1 past
CLNN Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-0.46 | FQ end Sep/2026 | Call: tbd
Clene Inc. topped Q3 earnings estimates per Zacks headline; no figures provided in the text.
Market Overview
Stock performance and key metrics
CNM-Au8
Relapsing Multiple Sclerosis
CNMAu8
Amyotrophic Lateral Sclerosis
CNM-ZnAg
Covid19
gold nanocrystals
Multiple Sclerosis
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
CNM-Au8 | Phase 3 | Relapsing Multiple Sclerosis | - | - |
CNMAu8 | Phase 2 | Amyotrophic Lateral Sclerosis | - | - |
CNM-ZnAg | Phase 2 | Covid19 | - | - |
gold nanocrystals | Phase 2 | Multiple Sclerosis | - | - |
Frequently asked questions
What is in Clene Inc.'s drug pipeline?→
CatalystAlert tracks 4 drug candidates in Clene Inc.'s (CLNN) pipeline across Phase 3, Phase 2. Its lead program is CNM-Au8 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Clene Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Clene Inc. (CLNN) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track CLNN biotech catalysts?→
Add CLNN to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Clene Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.